Icon

DOXORUBICIN HYDROCHLORIDE (nda050467)- (10MG/VIAL,20MG/VIAL,50MG/VIAL,150MG/VIAL)

DOXORUBICIN HYDROCHLORIDE PFIZER
10MG/VIAL,20MG/VIAL,50MG/VIAL,150MG/VIAL
No No
Expired Expired
None None
None No
Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated:  as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer.  for the treatment of: acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma.
4 0 3
Total Other Developers 13
Drugs with Suitability No
10MG/VIAL ** ** - - -
20MG/VIAL ** ** - - -
50MG/VIAL ** ** - - -
150MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** ******** *** *********** **** ***** *******, **** *****, ***** (**) *****, ****** ****** (***) ***
****** ****** ****** ******** ******* ******* *********** **** **. *-*, *-*, *-**, *****-*** *******-********* ******-********* *************, *************, ** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.